Cases & Deals

Share

JumpStart invests in Thermalin Diabetes

March 2010

Client(s) JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by Thermalin Diabetes, Incorporated, a developer of portfolios of insulin analogs to address both the fast-acting and long-acting insulin markets.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.